A randomized, double-blind, placebo-controlled, pilot study to evaluate the efficacy and safety of venlafaxine extended-release in depressed and anxious patients with multiple, unexplained somatic symptoms.
Phase of Trial: Phase IV
Latest Information Update: 09 Oct 2009
At a glance
- Drugs Venlafaxine (Primary)
- Indications Somatoform disorders
- Focus Therapeutic Use
- Sponsors Wyeth
- 30 Oct 2007 New trial record.